Texas Oncology - Weslaco

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Follicular lymphoma1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• BriaCell Therapeutics Corporation1 trial
• Epizyme, Inc.1 trial

Running trials

• Recruiting

  Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  NCT06072612· Phase 3· BriaCell Therapeutics Corporation· Source

  Contact: Nereida Salinas, RN

• Active, not recruiting

  A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

  NCT04224493· Phase 3· Epizyme, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Metastatic breast cancer1 recruiting